ZPP Newsletter
What's new
The world is changing and so are our lifestyles which means that today’s society is exposed to a much greater extent to the so-called diseases of affluence. Their early detection is enabled, among other things, by modern diagnostic imaging. In Poland, there is a sufficient number of diagnostic apparatuses available and the available research indicates that the possibilities of this equipment are much greater than is their actual use.
Dispute about 1% of pharmacies in a voivodeship ends. The SAC on the side of patients and entrepreneurs
A written justification of the key and precedent judgment of the Supreme Administrative Court regarding the provisions on 1% of pharmacies in a voivodship has been published. The SAC confirmed that the principle of universal succession apply to licences for running pharmacies, and pharmacy licenses acquired through capital acquisitions by law are transferred to the purchaser. Thus, the Court confirmed the rights of entrepreneurs who in the last dozen or so years had been buying pharmacies, also from the State Treasury.
Commentary of the Union of Entrepreneurs and Employers on regulatory proposals how to remedy the problem of payment blockages
Delayed payments between entrepreneurs are one of the most serious economic problems in Poland. Our country is not the only one suffering from this issue, of course – no member state of the European Union has developed a fully effective solution, and payment blockages constitute a major problem also abroad. Research shows that more than 80% of entrepreneurs have come across delayed payments in Poland. One must bear in mind that the group of entities for which payment blockages are a particularly dangerous phenomenon are entrepreneurs from the SME sector.
Position of the Union of Entrepreneurs and Employers on the supplementary protection certificate for medicinal products
Beginning with Council Regulation (EEC) No 1768/92 of June 18th, 1992, followed by Regulation (EC) No 469/2009 of the European Parliament and of the Council of May 6th, 2009, concerning supplementary protection certificates for medicinal products, the EU legislator introduced into the legal order an instrument to extend the protection of medicinal products beyond the duration of basic patent protection.
